OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-7.74%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$884M
AUM Growth
+$884M
Cap. Flow
-$28.1M
Cap. Flow %
-3.18%
Top 10 Hldgs %
89.11%
Holding
24
New
–
Increased
1
Reduced
3
Closed
1

Top Buys

1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.88M

Top Sells

1
MORF
Morphic Holding, Inc. Common Stock
MORF
$29M
2
AVIR icon
Atea Pharmaceuticals
AVIR
$2.16M
3
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$580K
4
EPIX icon
ESSA Pharma
EPIX
$248K

Sector Composition

1 Healthcare 99.44%
2 Financials 0.56%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NUVB icon
1
Nuvation Bio
NUVB
$1.02B
$263M 29.73% 28,212,376 – –
REPL icon
2
Replimune Group
REPL
$422M
$192M 21.78% 5,008,245 – –
MORF
3
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$101M 11.48% 1,767,350 -505,128 -22% -$29M
KRON
4
DELISTED
Kronos Bio
KRON
$91.4M 10.35% 3,818,283 – –
IMA
5
ImageneBio, Inc. Common Stock
IMA
$150M
$31.6M 3.57% 2,249,123 – –
GOSS icon
6
Gossamer Bio
GOSS
$562M
$27M 3.05% 3,320,608 – –
SPRB
7
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$24.2M 2.74% 2,161,022 – –
IMUX icon
8
Immunic
IMUX
$80.9M
$21.9M 2.48% 1,788,160 – –
PRTK
9
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$17.7M 2.01% 2,600,410 – –
ARQT icon
10
Arcutis Biotherapeutics
ARQT
$1.86B
$17M 1.93% 623,836 – –
SANA icon
11
Sana Biotechnology
SANA
$777M
$16.6M 1.88% 843,750 – –
AVIR icon
12
Atea Pharmaceuticals
AVIR
$267M
$16M 1.82% 746,868 -100,340 -12% -$2.16M
SYRS
13
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$12.4M 1.4% 2,274,831 +712,331 +46% +$3.88M
ALPN
14
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$11.6M 1.31% 1,284,900 – –
EPIX icon
15
ESSA Pharma
EPIX
$11.4M
$9.38M 1.06% 328,196 -8,673 -3% -$248K
CMPI
16
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$7.96M 0.9% 1,335,050 – –
OMEG
17
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$4.99M 0.56% 501,000 – –
CDTX icon
18
Cidara Therapeutics
CDTX
$1.66B
$4.05M 0.46% 2,005,249 – –
FGEN icon
19
FibroGen
FGEN
$47.8M
$3.48M 0.39% 130,646 – –
OBSV
20
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.03M 0.34% 999,364 – –
TRVI icon
21
Trevi Therapeutics
TRVI
$883M
$2.84M 0.32% 1,263,408 – –
IMCR icon
22
Immunocore
IMCR
$1.62B
$2.01M 0.23% 51,535 – –
JNCE
23
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.87M 0.21% 275,513 – –
PVLA
24
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
– – -225,741 Closed -$580K